A Study of the Efficacy and Safety of Brensocatib in Participants With Chronic Rhinosinusitis Without Nasal Polyps (CRSsNP)
Clinical trial NCT06013241 · COMPLETED
Trial details
- NCT number
- NCT06013241
- Sponsor
- Insmed Incorporated
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-30
- Primary completion
- 2025-09-30
- Enrollment
- 288
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.